Literature DB >> 23642193

Drug-loaded fluorescent cubosomes: versatile nanoparticles for potential theranostic applications.

Sergio Murgia1, Sara Bonacchi, Angela M Falchi, Sandrina Lampis, Vito Lippolis, Valeria Meli, Maura Monduzzi, Luca Prodi, Judith Schmidt, Yeshayahu Talmon, Claudia Caltagirone.   

Abstract

In this work, monoolein-based cubosomes were doped with two fluorescent probes, namely, fluorescein and dansyl, properly modified with a hydrocarbon chain to increase their encapsulation efficiency within the monoolein palisade. The same nanocarriers were also loaded with quercetin, a hydrophobic molecule with potential anticancer activity. Particularly, the cubosomes doped with the modified fluorescein probe were successfully exploited for single living cell imaging. The physicochemical and photophysical characterizations reported here, along with the well-known ability of cubosomes in hosting molecules with pharmaceutical interest, strongly encourage the use of these innovative fluorescent nanocarriers for theranostic purposes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23642193     DOI: 10.1021/la401047a

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  13 in total

Review 1.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

2.  Synthesis, spectroscopic properties, and biological applications of eight novel chlorinated fluorescent proteins-labeling probes.

Authors:  Xianglong Wu; Min Tian; Wutu Fan; Yalei Pan; Yuankun Zhai; Yinbo Niu; Chenrui Li; Tingli Lu; Qibing Mei
Journal:  J Fluoresc       Date:  2014-02-04       Impact factor: 2.217

Review 3.  A Versatile Nanocarrier-Cubosomes, Characterization, and Applications.

Authors:  Cristiana Oliveira; Celso J O Ferreira; Miguel Sousa; Juan L Paris; Ricardo Gaspar; Bruno F B Silva; José A Teixeira; Pedro Ferreira-Santos; Claudia M Botelho
Journal:  Nanomaterials (Basel)       Date:  2022-06-29       Impact factor: 5.719

4.  Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.

Authors:  Mohammed M Mehanna; Rana Sarieddine; Jana K Alwattar; Racha Chouaib; Hala Gali-Muhtasib
Journal:  Int J Nanomedicine       Date:  2020-12-01

5.  Comprehensive and comparative studies on nanocytotoxicity of glyceryl monooleate- and phytantriol-based lipid liquid crystalline nanoparticles.

Authors:  Jakub Jagielski; Łucja Przysiecka; Dorota Flak; Magdalena Diak; Zuzanna Pietralik-Molińska; Maciej Kozak; Stefan Jurga; Grzegorz Nowaczyk
Journal:  J Nanobiotechnology       Date:  2021-06-03       Impact factor: 10.435

6.  Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity.

Authors:  Rengarajan Baskaran; Thiagarajan Madheswaran; Pasupathi Sundaramoorthy; Hwan Mook Kim; Bong Kyu Yoo
Journal:  Int J Nanomedicine       Date:  2014-06-26

7.  Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.

Authors:  Mona M Saber; Abdulaziz M Al-Mahallawi; Noha N Nassar; Björn Stork; Samia A Shouman
Journal:  BMC Cancer       Date:  2018-08-15       Impact factor: 4.430

8.  AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.

Authors:  Dorota K Flak; Vivian Adamski; Grzegorz Nowaczyk; Kosma Szutkowski; Michael Synowitz; Stefan Jurga; Janka Held-Feindt
Journal:  Int J Nanomedicine       Date:  2020-10-05

Review 9.  Cubic and hexagonal liquid crystals as drug delivery systems.

Authors:  Yulin Chen; Ping Ma; Shuangying Gui
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

10.  Controlling the Kinetics of an Enzymatic Reaction through Enzyme or Substrate Confinement into Lipid Mesophases with Tunable Structural Parameters.

Authors:  Marco Mendozza; Arianna Balestri; Costanza Montis; Debora Berti
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.